ES Cell International Pte Ltd. develops human embroyonic stem cell technologies for research and commercial applications. It develops an array of intellectual property in the fields of drug discovery, diagnostics, and therapeutics based on stem cell technology. The company was founded by Ariff Bongso, Robert Klupacs, Martin F. Pera, Reubinoff Benjamin and Alan Osborne Trounson in 2000 and is headquartered in Singapore.

LifeScan manufactures and markets blood glucose monitoring systems. The company’s product portfolio includes blood glucose meters, test strips, lancing devices, and diabetes management software solutions, hospital meters, data management systems, glucose control solutions, and linearity test kits. Additionally, the company provides pre-installation project management, installation, and post installation support services, including on-site and on-line training programs through authorized distributors such as doctors, pharmacists, and diabetes educators. Lifescan was founded in 1981 and is headquartered in Milpitas, California.  The company currently operates as a subsidiary of Johnson & Johnson and has facilities in Inverness, Scotland; Burnaby, British Columbia, Canada; and Cabo Rojo, Puerto Rico.

Dalian Dien Bioengineering Co., Ltd., established on 1998-07-03, Business scope includes licensed projects:pharmaceutical production,Import and export,Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Engineering and Technology Research and Experimental Development,Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Fermentation process optimization technology research and development,Biochemical product technology research and development,Sales of Class I Medical Devices,Production of Class I Medical Devices,Sales of daily chemical products,Manufacturing of daily chemical products,R&D of industrial enzyme preparations,property management,Non-residential real estate leases,housing lease,business management,Park Management Services,Supply Chain Management Services,Legal advice(Does not include law firm business),Financial Advisory,tax service,Environmental Consulting Services,Business agency service,Project planning and public relations services,Bidding agency service,Government Procurement Agency Services(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Merck (d.b.a. EMD Millipore in the U.S. and Canada) is a German chemical and pharmaceutical company. Merck, also known as “German Merck” and “Merck Darmstadt”, was founded in Darmstadt, Germany, in 1668, making it the world's oldest operating chemical and pharmaceutical company. The company was privately owned until going public in 1995. However, the Merck family still controls a majority (≈70%) of the company's shares. Following World War I, Merck lost possession of its foreign sites, including the Merck & Co. subsidiary in the United States. Merck & Co., which operates as Merck Sharp and Dohme (MSD) outside the U.S. and Canada, is now an independent company. Merck KGaA operates mainly in Europe, Africa, Asia, Oceania and Latin America. Since Merck & Co. holds the rights to the Merck name in the U.S. and Canada, the company operated under the umbrella brand EMD Chemicals in North America, and since 2010 as EMD Millipore (after the acquisition of Millipore Corporation), formed from the initials of Emanuel Merck, Darmstadt. Founded in 1668 in Darmstadt, Merck KGaA of Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The success of the export business to the United States led in 1887 to the establishment of an office in New York, which gave rise to their subsidiary [Merck & Co.](http://www.crunchbase.com/organization/merck-co-inc) four years later. Owing to World War I, Merck & Co. was expropriated in 1917. The two companies have been separate every since. Merck KGaA Subsidiaries: - [Merck Consumer Healthcare](http://www.crunchbase.com/organization/merck-consumer-healthcare) - [Merck Performance Materials](http://www.crunchbase.com/organization/merck-performance-materials)

MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Westlake Village, California, the company was founded in February 1991. However, its present form is a result of a 2003 merger of three companies owned by Alfred E. Mann, Pharmaceutical Discovery Corporation (PDC), the cancer vaccine developer CTL ImmunoTherapies, Inc., and its sister company Allecure Corp, which was developing a allergy vaccine technology. MannKind Corporation was named after its founder, Alfred Mann. One of the former companies, Pharmaceutical Discovery, was purchased in 2001 from Solomon Steiner; with that purchase MannKind acquired the Technosphere molecule and Medtone inhaler, upon which was developed its lead product, Afrezza (inhalable insulin).

Prosidion Ltd. manufactures products for treatment of metabolic diseases such as diabetes and obesity. The company's products include oral inhibitors of dipeptidyl peptidase, glycogen phosphorylase inhibitor and glucokinase activator. It was founded in 2003 and is headquartered in Oxford, UK

Boryung Corp. engages in the manufacture of of drug products. Its main products include Kanarb, Dukarb, Tuvero, TODULA, BESTO, and gelfosM. Its products include cardiovascular, antibiotics, anticancer, amino acid, cosmetics, gastrointestinal, and API. The company was founded on November 11, 1963 and is headquartered in Seoul, South Korea.

Beijing Ershi Medical Health Management Co., Ltd., established on 2019-07-30, The scope of business includes the sale of food;health management,Health Advisory(Except for medical treatment activities subject to approval);technology development,consult,Serve,to promote;Computer System Services;Medical Research and Experimental Development;Sales of Class II Medical Devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Sale of food and items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Gansu Kaiyuan Biotechnology Development Center Co., Ltd., established on 1997-06-30, Business scope includes licensed projects:food production;Health food production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)*** General project:Healthy food(prepackaged)Sales;food sales(Only sell prepackaged food);Agricultural Science Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;business training(Does not include education and training,Vocational skills training and other licensed training).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)***

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Imcyse is a clinical stage biopharmaceutical company pioneering the development of a new class of active specific immunotherapies for the treatment of severe chronic autoimmune diseases. The company’s unique technology platform allows it to locally target immune cells involved in the destruction of the diseased organ. This platform is based on the administration of Imotopes™, which are specifically modified peptides, allowing for the generation of cytolytic CD4 T-cells, that specifically eliminate antigen-presenting cells and autoantigen specific lymphocytes. Imcyse’s approach, sustained over time, helps to prevent and treat diseases with no current therapeutic alternative and to potentially cure patients without impairing immune defense. The company has established proof of concept in several indications and has completed its first clinical trial in type 1 diabetes with promising results. Beyond type 1 diabetes, Imcyse is developing a pipeline of Imotopes™ for the treatment of several autoimmune diseases.

Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany.

Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

Beijing Huayuan Bochuang Technology Co., Ltd., established on 2008-06-26, Business scope includes research,developing biotech drugs;technical consulting,Technical Services,technology transfer.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Hefei Zhongkepu Ruisheng Biomedical Technology Co., Ltd., established on 2015-07-16, Business scope includes research on biomedical engineering technology,to develop,transfer,consultation service,Biomedical Experimental Technology Services,Experimental technology consulting service and transfer;Biological experiment reagent,Development of Consumables for Biological Experiments,Sales;Drug and medical information consultation service;Self-operated and agent import and export business of various commodities and technologies(Except for those restricted or prohibited by the state);clinical body fluid,blood test;Clinical tissue and cell biology assays,Molecular genetics professional testing;Medical testing consultation;Medical Information Consultation;data collection;Big Data Services and Applications;Research and development of biomedical technology and software technology,technical consulting,Technical Services,technology transfer.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.

Hybrigenics Pharma is a bio-pharmaceutical company with a focus on research and development of new targets and therapies against cancer.Hybrigenics Pharma has stopped the development of inecalcitol, a vitamin D receptor agonist.Hybrigenics Pharma's research program investigates the action of enzymes called Deubiquitinating Enzymes (DUBs) in the recycling of onco-proteins and the potential activity of proprietary patented DUB inhibitors against various cancer indications.